article_snippet.sent: A new antibody injection could 'wipe out advanced cancer' by rooting out and obliterating tumours, scientists have revealed.
article_snippet.sent: The team at Stanford University School of Medicine believe the laboratory-engineered antibodies could eradicate not only primary tumours, but also distant metastases that have spread through the body.
article_snippet.sent: A new study has suggested an antibody injection could 'wipe out cancer' by rooting out and eradicating both primary tumours and distant metastases, where cancer has spread to other parts of the body .
article_snippet.sent: Researchers isolated the antibodies from mice that were found to be resistant to the cancers.
article_snippet.sent: Researchers then injected the antibodies from mice that were found to be resistant to the cancers, along with chemicals that activated signalling cells, known as dendritic cells, into cancerous mice.
article_snippet.sent: mice that were found to be resistant to the cancers mounted an immune response and were found to remain cancer-free for more than a year.
article_snippet.sent: Dr Yaron Carmi, the lead author, discovered both antibodies and the signalling, dendritic cells are both antibodies and the signalling, dendritic cells crucial for tumour elimination. '
article_snippet.sent: the lead author added when The team at Stanford University School of Medicine disabled the antibodies' ability to bind to the tumours, or the signalling, dendritic cells ability to ingest the tumours, the signalling, dendritic cells failed to eradicate cancer. '
article_snippet.sent: By adding chemicals that encouraged the growth of the signalling, dendritic cells, to the antibodies', the researchers were able to eliminate six different types of cancer - two melanomas, lymphoma, breast, lung and pancreatic cancer. '
article_snippet.sent: While the researchers tested the researchers process in mice, the researchers said in vitro work with human cancer cells indicates a similar immune-cell response.
article_snippet.sent: To confirm that, blood plasma from 10 healthy donors was pooled to collect antibodies against four cancers from patients: two lung and two mesothelioma cancers.
article_snippet.sent: The antibodies with the stimulation factors were able to activate the two lung cancer patients' dendritic cells in vitro.
article_snippet.sent: With the cells from the two mesothelioma cancer patients, The antibodies with the stimulation factors induced T-cell proliferation in vitro under the same experimental conditions.